MP21-01 LONG-TERM SURVIVAL OUTCOMES WITH INTRAVESICAL NANOPARTICLE ALBUMIN-BOUND PACLITAXEL FOR RECURRENT NON-MUSCLE INVASIVE BLADDER CANCER AFTER PREVIOUS BACILLUS CALMETTE-GUÉRIN THERAPY | Zendy

AI Assistant Blog Pricing

MP21-01 LONG-TERM SURVIVAL OUTCOMES WITH INTRAVESICAL NANOPARTICLE ALBUMIN-BOUND PACLITAXEL FOR RECURRENT NON-MUSCLE INVASIVE BLADDER CANCER AFTER PREVIOUS BACILLUS CALMETTE-GUÉRIN THERAPY

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.